Saccomano Nicholas A
SEC insider (Form 3/4/5 filer). CIK 0001609284. President and CEO at OnKure Therapeutics, Inc. (OKUR). 22 reported Form 4/5 transactions since Sep 2024; latest on Sep 21, 2026. Located in BOULDER, CO.
Companies Saccomano Nicholas A has filed insider reports for
- OnKure Therapeutics, Inc. (OKUR): Director, Officer, President and CEO
Saccomano Nicholas A
CIK: 0001609284
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
OnKure Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (22 total)
- Sep 21, 2026OKUR
OnKure Therapeutics, Inc.
SaleDirect87 shares at avg. $2.97$258.755 - Aug 7, 2026OKUR
OnKure Therapeutics, Inc.
AwardDirectEmployee Stock Option (right to buy)
8.4K shares- - Aug 7, 2026OKUR
OnKure Therapeutics, Inc.
DispositionDirectEmployee Stock Option (right to buy)
8.4K shares- - Aug 7, 2026OKUR
OnKure Therapeutics, Inc.
DispositionDirectEmployee Stock Option (right to buy)
1.5K shares- - Aug 7, 2026OKUR
OnKure Therapeutics, Inc.
DispositionDirectEmployee Stock Option (right to buy)
16.9K shares- - Aug 7, 2026OKUR
OnKure Therapeutics, Inc.
AwardDirectEmployee Stock Option (right to buy)
1.5K shares- - Aug 7, 2026OKUR
OnKure Therapeutics, Inc.
AwardDirectEmployee Stock Option (right to buy)
2.4K shares- - Aug 7, 2026OKUR
OnKure Therapeutics, Inc.
DispositionDirectEmployee Stock Option (right to buy)
2.4K shares- - Aug 7, 2026OKUR
OnKure Therapeutics, Inc.
AwardDirectEmployee Stock Option (right to buy)
150K shares- - Aug 7, 2026OKUR
OnKure Therapeutics, Inc.
AwardDirectEmployee Stock Option (right to buy)
16.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 21, 2026 | OKUR OnKure Therapeutics, Inc. | Sale | 87 | $2.97 | $259 | Direct |
| Aug 7, 2026 | OKUR OnKure Therapeutics, Inc. | Award Employee Stock Option (right to buy) | 8,449 | - | - | Direct |
| Aug 7, 2026 | OKUR OnKure Therapeutics, Inc. | Disposition Employee Stock Option (right to buy) | 8,449 | - | - | Direct |
| Aug 7, 2026 | OKUR OnKure Therapeutics, Inc. | Disposition Employee Stock Option (right to buy) | 1,485 | - | - | Direct |
| Aug 7, 2026 | OKUR OnKure Therapeutics, Inc. | Disposition Employee Stock Option (right to buy) | 16,898 | - | - | Direct |
| Aug 7, 2026 | OKUR OnKure Therapeutics, Inc. | Award Employee Stock Option (right to buy) | 1,485 | - | - | Direct |
| Aug 7, 2026 | OKUR OnKure Therapeutics, Inc. | Award Employee Stock Option (right to buy) | 2,359 | - | - | Direct |
| Aug 7, 2026 | OKUR OnKure Therapeutics, Inc. | Disposition Employee Stock Option (right to buy) | 2,359 | - | - | Direct |
| Aug 7, 2026 | OKUR OnKure Therapeutics, Inc. | Award Employee Stock Option (right to buy) | 150,000 | - | - | Direct |
| Aug 7, 2026 | OKUR OnKure Therapeutics, Inc. | Award Employee Stock Option (right to buy) | 16,898 | - | - | Direct |
1-10 of 22 transactions